Those with American Heart Association careers, along with many other related professionals, will benefit from an upcoming conference.

The American Heart Association will host the Arteriosclerosis, Thrombosis and Vascular Biology 2011 Scientific Sessions from April 28th to 30th in Chicago. The conference will feature almost 700 abstracts and 100 oral presentations dealing with research on vascular biology and disease.

The conference is the result of a joint effort among the American Heart Association's Council on Arteriosclerosis, Thrombosis and Vascular Biology, the AHA Council on Peripheral Vascular Disease, and the Society of Vascular Surgery.

"This is the most comprehensive meeting worldwide that reports on fundamental research exploring the mechanisms underlying atherosclerosis, blood clotting and related disorders, and peripheral vascular disease," Murray W. Huff, Ph.D., director of the Vascular Biology Research Group for the Robarts Research Institute at the University of Western Ontario and co-chair of the conference, said in a statement.

In the past, research presented at the ATVB conference has led to:

• Vast improvements in various therapies for cardiovascular care.
• Better drugs to prevent blood vessel clots.
• Clinical stem cell trials to stimulate new blood vessel growth.
• Discoveries of genes that explain vascular disease.
• Improved predictability of vascular disease risk.
• New treatments for vascular disease.

"Leading-edge basic science research will be presented side-by-side with emerging frontiers in clinical medicine," Robert Hegele, M.D., director of the Blackburn Cardiovascular Genetics Laboratory at Robarts and the London Regional Genomics Centre and co-chair of the conference, said.

Labels: American Heart Association careers